---
title: 'Medical Outcomes Liaison at Alumis'
canonical: 'https://feeny.ai/job/medical-outcomes-liaison-alumis-united-states-6y700jmft07k'
type: 'job'
last_seen: '2026-09-15'
---

# Medical Outcomes Liaison at Alumis

- **Company:** Alumis
- **Location:** United States
- **Posted:** 2026-06-17
- **Last confirmed live:** 2026-09-15
- **Apply:** https://job-boards.greenhouse.io/alumis/jobs/5258581008

## Job description

Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.

The Medical Outcomes Liaison (MOL) is a field-based Medical Affairs professional responsible for engaging payers and healthcare decision makers (HCDMs). This role focuses on communicating the clinical and economic value of Alumis therapies to support formulary access, reimbursement, and patient outcomes. This is a critical role supporting pre-launch and launch readiness, translating clinical and HEOR evidence into meaningful value narratives for population-based stakeholders.

Key Responsibilities:

- Build and maintain relationships with payers, PBMs, and health systems
- Deliver clinical, real-world, and health economic evidence to inform access decisions
- Support payer engagement strategy, including pre-launch activities and value communication
- Contribute to HEOR and evidence generation plans, including AMCP dossier support
- Gather insights on payer needs and market dynamics to inform strategy
- Collaborate cross-functionally with Medical Affairs, HEOR, and Market Access teams

Qualifications:

- Advanced degree required (PharmD, PhD, MD, MPH, or equivalent)
- 5+ years of experience in Medical Affairs, HEOR, Market Access, or related field
- Experience engaging payers or healthcare decision makers strongly preferred
- Strong understanding of HEOR, RWE, and U.S. payer landscape
- Excellent communication and stakeholder engagement skills

What You Bring:

- Ability to translate complex data into clear, payer-relevant value insights
- Strong collaboration skills in a cross-functional, fast-paced environment
- Strategic mindset with a focus on value-based care and patient access

## Why Join Alumis

- Be part of a launch-stage biotech shaping the future of TYK2 inhibition
- Play a key role in defining the value story for a novel therapy
- Work in a highly collaborative, science-driven Medical Affairs organization

This position is primarily remote with travel up to roughly 50–75% We have 3 MOL roles (geographically dispersed) that we are working to fill.

The salary range for this position is $200,00 USD to 265,000 USD annually. This salary range is an estimate, and the actual salary may very based on the Company’s compensation practices degree and background.

Alumis compensation packages include generous stock option grants for all employees as well as an annual bonus program.

Other benefits include:

- Health insurance premiums paid at 90% for employee, 80% for dependents
- Free access to Genentech Bus & Ferry Share program
- $100 monthly cell phone stipend
- Unlimited PTO for Exempt employees
- Free onsite gym and a kitchen stocked with yummy snacks and drinks!

We are a hard-working, collaborative team on a mission to transform patient’s lives-- and we aspire to elevate, challenge and nurture one another along the way.

Alumis Inc. is an equal opportunity employer.

## About Alumis

## Company Overview
- **One-liner**: Alumis is a public biotechnology company pioneering precision-targeted therapies for immune-mediated diseases, with a late-stage pipeline and proprietary data analytics platform.
- **Entity Type**: Public (ticker symbol not confirmed in available sources; reports quarterly financials as a public company)
- **Headquarters**: South San Francisco, California, United States
- **Founded**: 2021
- **Founders**: Incubated by Foresite Labs; leadership includes Martin Babler (President, CEO and Chairman of the Board)

## Core Business
- **Primary industry**: Biotechnology – immune-mediated disease therapeutics.
- **Target customers**: Patients with immune-mediated diseases (e.g., psoriasis, lupus), physicians, and healthcare systems (B2B/B2C).
- **Mission statement**: Transform treatment for immune-mediated diseases, empower people to reimagine their lives.

## Products & Services
- **Envudeucitinib (oral TYK2 inhibitor)**: Late-stage candidate for plaque psoriasis; Phase 3 trials demonstrated early and robust improvements in skin clearance, quality of life, and psoriasis symptoms. Designed as a next-generation oral therapy.
- **Proprietary Data Analytics Platform**: Internal platform that integrates scientific insights to select the right target, molecule, indication, patient, and endpoint.
- **Pipeline of targeted therapies**: Additional programs for other immune-mediated diseases (specific indications not publicly detailed), all aiming to replace broad immunosuppression with precise treatments.

## Market Standing
- **Valuation/Market Cap**: Not disclosed in available sources.
- **Key Metric**: Total funding (private) not publicly available; as a public company, annual revenue is not yet disclosed (likely pre-revenue or early commercial stage).
- **Notable Investors/Partners**: Incubated by Foresite Labs; board includes members from Foresite Capital, Arvinas, and other biotech leadership.
- **Growth Signals**: 
  - Active late-stage Phase 3 trials with positive results for plaque psoriasis (March 2026).
  - Employee headcount of 246 (as of mid-2026), growing ~1.3% monthly.
  - 13 active job postings, up 30% in the month prior.
  - Listed job openings span Clinical Development, Commercial, Research & Technical Operations, and G&A.

## Competitive Advantages
- **Precision approach**: Proprietary data analytics platform enables smarter target selection and clinical trial design, reducing failure risk.
- **Late-stage portfolio**: Envudeucitinib already in Phase 3, targeting a large market (plaque psoriasis) with potential to become a leading oral therapy.
- **Experienced leadership**: Deep biotech expertise from CEO Martin Babler and a seasoned leadership team.
- **Focus on patient outcomes**: Differentiates from broad immunosuppressants by aiming for efficacy without life-limiting side effects.

## Strategic Focus
- Advance Envudeucitinib through regulatory approval and launch for plaque psoriasis.
- Expand pipeline into additional immune-mediated indications (rheumatology, lupus, etc.).
- Leverage data analytics to optimize clinical development and commercialization.
- Build commercial infrastructure (hiring VP of Medical Affairs, Director of Market Access, etc.).

## Why Work Here
- **Culture**: Emphasizes openness, collaboration, and respect; employee-led Culture Team drives engagement, growth, and inclusion.
- **Values**: Challenge conventional wisdom, nurture teammates, elevate each other.
- **Benefits**: Medical, dental, vision, 401k, unlimited time off, pet insurance, Employee Stock Purchase Plan, commuter benefits (including company-paid access to Genentech Bus and Ferry lines).
- **Work Environment**: Mostly based in South San Francisco; some roles offer remote flexibility (indicated as "United States" in job listings). Hybrid likely for local roles.
- **Growth**: High-performance, mission-driven environment with expanding headcount and pipeline; opportunity to impact transformative therapies.
- **Job Openings**: Currently hiring for senior scientific, clinical, commercial, and operational roles (Associate Director Biostatistics, Vice President Medical Affairs, Director Market Access, etc.).

## Sources
1. [alumis.com – Company Website](https://www.alumis.com/)
2. [alumis.com – Careers Page](https://www.alumis.com/careers/)
3. [alumis.com – About / Leadership](https://www.alumis.com/about/)
4. [alumis.com – Job Opportunities](https://www.alumis.com/careers/job-opportunities/)
5. [LinkedIn – Alumis Company Profile](https://www.linkedin.com/company/alumis-com)

## Other roles at Alumis

- [Manager, Medical Congress & Events Management](https://feeny.ai/job/manager-medical-congress-events-management-alumis-remote-4vzz1qvnryxw)
- [Director - Commercial Systems, Data Management & Governance](https://feeny.ai/job/director-commercial-systems-data-management-governance-alumis-remote-va6d454zc9hg)
- [Director, Medical Affairs](https://feeny.ai/job/director-medical-affairs-alumis-south-san-francisco-t1kf4ejqcaxe) — South San Francisco, CA
- [Senior Manager, People & Culture Operations](https://feeny.ai/job/senior-manager-people-culture-operations-alumis-south-san-francisco-5h92h9gc4d8j) — South San Francisco, CA
- [Senior Director, Medical Strategy and Operations](https://feeny.ai/job/senior-director-medical-strategy-and-operations-alumis-united-states-bsawqvwmzrka) — United States
- [Senior Scientist I Analytical Development](https://feeny.ai/job/senior-scientist-i-analytical-development-alumis-south-san-francisco-myefvg693tkw) — South San Francisco, CA
- [Senior Scientist, Drug Product Development](https://feeny.ai/job/senior-scientist-drug-product-development-alumis-south-san-francisco-rgdk6p0j7s02) — South San Francisco, CA
- [Senior/Executive Medical Director, Clinical Development (New Indications)](https://feeny.ai/job/senior-executive-medical-director-clinical-development-new-indications-alumis-an6hzxfmf4bz) — South San Francisco, CA
- [Vice President Corporate Communications & Investor Relations](https://feeny.ai/job/vice-president-corporate-communications-investor-relations-alumis-south-san-epfvvrpa9016) — South San Francisco, CA
- [Vice President, Medical Affairs](https://feeny.ai/job/vice-president-medical-affairs-alumis-south-san-francisco-wf29rz4etq59) — South San Francisco, CA